Back to Search
MICHAEL HOGARTY, M.D.
M.D.
Pediatric Hematology & Oncology Physician
NPI: 1649294455Individual
Specialties, Licenses & Credentials
Pediatrics Physician
Pediatrics
Code: 208000000X
MD052675L(PA)
Pediatric Hematology & Oncology PhysicianPrimary
Pediatrics — Pediatric Hematology-Oncology
Code: 2080P0207X
MD052675L(PA)
Research & Publications (20)
ODC1 is a critical determinant of MYCN oncogenesis and a therapeutic target in neuroblastoma.
PMID 19047152·Cancer Res·2008
7-preclinical
The requirement for evasion of programmed cell death in neuroblastomas with MYCN amplification.
PMID 12880978·Cancer Lett·2003
6-review
No evidence for the presence of an imprinted neuroblastoma suppressor gene within chromosome sub-band 1p36.3.
PMID 12438240·Cancer Res·2002
8-other
Analysis of genomic imprinting at 1p35-36 in neuroblastoma.
PMID 11464906·Med Pediatr Oncol·2001
6-review
BIN1 inhibits colony formation and induces apoptosis in neuroblastoma cell lines with MYCN amplification.
PMID 11107117·Med Pediatr Oncol·2000
8-other
Identification of a 1-megabase consensus region of deletion at 1p36.3 in primary neuroblastomas.
PMID 11107105·Med Pediatr Oncol·2000
8-other
Mcl1 downregulation sensitizes neuroblastoma to cytotoxic chemotherapy and small molecule Bcl2-family antagonists.
PMID 19556859·Cancer Biol Ther·2009
8-other
Clinicopathological characteristics of ganglioneuroma and ganglioneuroblastoma: a report from the CCG and COG.
PMID 19530234·Pediatr Blood Cancer·2009
8-other
Predicting outcomes for children with neuroblastoma using a multigene-expression signature: a retrospective SIOPEN/COG/GPOH study.
PMID 19515614·Lancet Oncol·2009
4-observational
Small-molecule BH3 mimetics to antagonize Bcl-2-homolog survival functions in cancer.
PMID 19513945·Curr Opin Investig Drugs·2009
6-review
Clusterin, a haploinsufficient tumor suppressor gene in neuroblastomas.
PMID 19401549·J Natl Cancer Inst·2009
7-preclinical
Influence of neuroblastoma stage on serum-based detection of MYCN amplification.
PMID 19301388·Pediatr Blood Cancer·2009
8-other
Isolation and characterization of a novel Francisella sp. from human cerebrospinal fluid and blood.
PMID 18495864·J Clin Microbiol·2008
5-case
N-myc augments death and attenuates protective effects of Bcl-2 in trophically stressed neuroblastoma cells.
PMID 18193081·Oncogene·2008
8-other
Deregulated Wnt/beta-catenin program in high-risk neuroblastomas without MYCN amplification.
PMID 17724465·Oncogene·2008
8-other
Phase I Trial of G3139, a bcl-2 antisense oligonucleotide, combined with doxorubicin and cyclophosphamide in children with relapsed solid tumors: a Children's Oncology Group Study.
PMID 17442993·J Clin Oncol·2007
3-trial
Immunosurveillance and survivin-specific T-cell immunity in children with high-risk neuroblastoma.
PMID 17179106·J Clin Oncol·2006
8-other
Pediatric horner syndrome: etiologies and roles of imaging and urine studies to detect neuroblastoma and other responsible mass lesions.
PMID 17011859·Am J Ophthalmol·2006
5-case
Cutaneous metastatic chordoma with concomitant tuberous sclerosis.
PMID 16843131·J Am Acad Dermatol·2006
5-case
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 3401 CIVIC CENTER BLVD, CHILDREN'S HOSPITAL OF PHILADELPHIA - HEM/ONC
PHILADELPHIA, PA 19104 - Phone
- (215) 590-3535
Quick Facts
- NPI
- 1649294455
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile